Clinical Trial Update: Folinic Acid in Autism [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating folinic acid in autism has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Folinic acid (folinic acid)

Snippet

Sponsor: University of California, San Francisco | Conditions: Autism Spectrum Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-12-03